Breast Cancer
Panel 08 - The Radiobiological Bases of Novel Radiation Treatment Schemes for Breast Cancer
10/23/2018
4:45 PM - 6:15 PM
Location: Room 006
Session Type: Panel
1.50 AMA PRA Category 1 Credits™
1.50 CAMPEP Credits
1.50 MDCB Credits
Panel presentations will have each speaker addressing their respective areas of expertise. Dr. Brunt will detail the FAST-Forward trial results of whole breast hypofractionation in one week. The technique and results of IORT at the time of breast lumpectomy will be described by Dr. Orecchia or a designated representative. Dr. Rachel Blitzblau will update intact tumor irradiation with a single fraction as up-front treatment before any planned surgery or as single modality therapy. The early results of 3-fraction APBI of the Triumph-T trial will be detailed by Dr. A Khan. And, Dr. George Wilson or a designated radiation biology dignitary will discuss in-depth the radiobiological principles upon which the various clinical results of these hypofractionation schemes are based upon.
Learning Objectives:
- Assess the utility of altered fractionation in early stage breast cancer .
- Explain the radiobiological bases upon which altered fractionation for breast cancer is derived from.
Presentations:
4:45 PM - 5:05 PM
Single-Fraction Upfront Treatment of Breast Cancer
Speaker:
5:25 PM - 5:45 PM
Hypofractionation for Whole Breast Irradiation in 5 days (Fast Forward Trial)
Speaker:
5:45 PM - 6:05 PM
The Radiobiology of Innovative Modes of Breast Cancer Treatment: From Tumor Microenvironment to Normal Tissue Effects
Speaker: – William Beaumont Hospital